US Patent Family Members and Approved Drugs for United States of America Patent: 2019314579
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for United States of America Patent: US2019314579
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 9,108,002 | 2025-01-21 | insulin degludec and insulin aspart | Novo Nordisk Inc. | RYZODEG 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
